Acta Veterinaria et Zootechnica Sinica ›› 2024, Vol. 55 ›› Issue (12): 5774-5783.doi: 10.11843/j.issn.0366-6964.2024.12.039

• Basic Veterinary Medicine • Previous Articles     Next Articles

Effect of Recombinant Serpins of Psoroptes ovis on Psoriasis-like Skin Inflammation in Mice

TIAN Yan(), YANG Fusheng, LI Yan'e, LIANG Youping, FAN Jie, WU Fangyan, GU Xiaobin*()   

  1. College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China
  • Received:2024-02-02 Online:2024-12-23 Published:2024-12-27
  • Contact: GU Xiaobin E-mail:2021203026@stu.sicau.edu.cn;guxiaobin198225@126.com

Abstract:

Our team previously found that recombinant serine protease inhibitors 4 and 5 (rPsoSP4 and rPsoSP5) of Psoroptes ovis could inhibit the enzymatic activities of chymotrypsin, trypsin and elastase in vitro, thus we speculated that these two recombinant proteins might have anti-inflammation activities. To confirm the above speculation, we assessed whether rPsoSP4 and rPsoSP5 could improve psoriatic-like skin inflammation in mice. BALB/c mice were randomly divided into 5 groups (n=6), Vaseline or imiquimod cream (IMQ) was applied daily on the back skin continuously for 6 days to establish the control group and psoriasis model groups. During this period, the psoriasis model groups were intradermal injected with PBS (IMQ group) or pET32a(+)-vector protein (IMQ+pET32a(+) group) or rPsoSP4 (IMQ+rPsoSP4 group) or rPsoSP5(IMQ+rPsoSP5 group), then the changes of psoriasis-like skin lesions were observed every day, and mice were sacrificed on the 7th day. Subsequently, the pathological changes and the transcription levels of IL-1β, IL-6, and TNF-α in the skin lesions among each group were compared. Results showed that IMQ induced psoriasis-like lesions were successfully established, and the mice appeared typical psoriasis-like lesions. Compared with the model group (IMQ group), IMQ+rPsoSP4 group can effectively attenuated psoriasis-like skin lesions, including significant inhibition of weight loss (from 4th to 6th day, P < 0.05, P < 0.01, P < 0.001) and reductions of skin erythema (5th and 6th day), skin scales (from 4th to 6th day), skin thickness (from 4th to 6th day) and PASI score (from 3rd to 6th day) in mice (P < 0.05, P < 0.001). Additionally, compared with the model group (IMQ group), IMQ+rPsoSP4 group showed that the pathological damage in the skin lesion was significantly reduced, accompanied by the significant decrease in epidermal thickness (P < 0.05) and the number of infiltrated inflammatory cells (P < 0.001). Moreover, there was a significantly decreased in mRNA levels of IL-1β, IL-6, and TNF-α in the skin lesion of IMQ+rPsoSP4 group in comparison with IMQ groups, while IMQ+rPsoSP5 group had no significant improvement on psoriatic lesions. In conclusion, rPsoSP4 could significantly improve psoriasis skin lesion in mice and has significant anti-inflammatory activity, while rPsoSP5 seemed to be no obvious effect.

Key words: Psoroptes ovis, rPsoSP4, rPsoSP5, psoriasis-like skin inflammation, anti-inflammatory activity

CLC Number: